UBS Group
CVS icon

UBS Group’s CVS Health CVS Stock Holding History

UBS Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2M Sell
183,800
-171,100
-48% -$13.2M ﹤0.01% 3046
2025
Q4 		$28.2M Sell
354,900
-144,600
-29% -$11.4M ﹤0.01% 2244
2025
Q3 		$37.7M Buy
499,500
+153,032
+44% +$10.5M 0.01% 1917
2025
Q2 		$23.9M Buy
346,468
+28,968
+9% +$1.9M ﹤0.01% 2184
2025
Q1 		$21.5M Sell
317,500
-117,900
-27% -$7.06M ﹤0.01% 2247
2024
Q4 		$19.5M Buy
435,400
+257,639
+145% +$14.5M ﹤0.01% 2342
2024
Q3 		$11.2M Buy
177,761
+33,061
+23% +$1.93M ﹤0.01% 2266
2024
Q2 		$8.55M Buy
144,700
+51,800
+56% +$3.24M ﹤0.01% 2354
2024
Q1 		$7.41M Sell
92,900
-298,600
-76% -$22.8M ﹤0.01% 2556
2023
Q4 		$30.9M Buy
391,500
+50,000
+15% +$3.56M 0.01% 1288
2023
Q3 		$23.8M Buy
341,500
+6,080
+2% +$431K 0.01% 1354
2023
Q2 		$23.2M Buy
335,420
+25,120
+8% +$1.79M 0.01% 1336
2023
Q1 		$23.1M Sell
310,300
-284,100
-48% -$23.8M 0.01% 1291
2022
Q4 		$55.4M Buy
594,400
+3,200
+0.5% +$309K 0.02% 750
2022
Q3 		$56.4M Buy
591,200
+115,400
+24% +$11.4M 0.02% 635
2022
Q2 		$44.1M Sell
475,800
-313,400
-40% -$30.6M 0.02% 798
2022
Q1 		$79.9M Sell
789,200
-126,900
-14% -$13.3M 0.03% 603
2021
Q4 		$94.5M Buy
916,100
+658,736
+256% +$60.9M 0.03% 624
2021
Q3 		$21.8M Buy
257,364
+25,000
+11% +$2.09M 0.01% 1443
2021
Q2 		$19.4M Buy
232,364
+101,697
+78% +$8.33M 0.01% 1512
2021
Q1 		$9.83M Sell
130,667
-494,233
-79% -$36M ﹤0.01% 1956
2020
Q4 		$42.7M Buy
624,900
+4,200
+0.7% +$273K 0.01% 872
2020
Q3 		$36.2M Buy
620,700
+80,700
+15% +$5.02M 0.01% 823
2020
Q2 		$35.1M Sell
540,000
-353,100
-40% -$22.2M 0.01% 773
2020
Q1 		$53M Sell
893,100
-298,100
-25% -$19.9M 0.03% 521
2019
Q4 		$88.5M Sell
1,191,200
-587,500
-33% -$41.3M 0.03% 497
2019
Q3 		$112M Buy
1,778,700
+1,510,100
+562% +$89.5M 0.04% 376
2019
Q2 		$14.6M Buy
268,600
+168,000
+167% +$9.05M 0.01% 1451
2019
Q1 		$5.42M Sell
100,600
-122,400
-55% -$7.55M ﹤0.01% 2143
2018
Q4 		$14.6M Sell
223,000
-151,000
-40% -$11.3M 0.01% 1298
2018
Q3 		$29.4M Buy
374,000
+266,200
+247% +$19M 0.01% 953
2018
Q2 		$6.94M Buy
107,800
+99,200
+1,153% +$6.54M ﹤0.01% 2056
2018
Q1 		$535K Sell
8,600
-1,396,000
-99% -$100M ﹤0.01% 4157
2017
Q4 		$102M Buy
+1,404,600
New +$102M 0.04% 409
2017
Q2 		– Sell
-120,000
Closed -$9.42M – 7716
2017
Q1 		$9.42M Buy
120,000
+119,900
+119,900% +$9.57M 0.01% 1559
2016
Q4 		$8K Sell
100
-49,900
-100% -$4.04M ﹤0.01% 7028
2016
Q3 		$4.45M Buy
+50,000
New +$4.72M ﹤0.01% 2125
2016
Q1 		– Sell
-74,100
Closed -$7.25M – 7711
2015
Q4 		$7.25M Hold
74,100
– – ﹤0.01% 1663
2015
Q3 		$7.15M Sell
74,100
-11,900
-14% -$1.25M 0.01% 1640
2015
Q2 		$9.02M Sell
86,000
-364,100
-81% -$37.2M 0.01% 1556
2015
Q1 		$46.5M Buy
450,100
+335,400
+292% +$33.9M 0.03% 538
2014
Q4 		$11M Buy
+114,700
New +$10.1M 0.01% 1423

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group's CVS Position: Q1 2026 in Review

UBS Group reduced its CVS Health (CVS) stake by 7.5% in Q1 2026, selling an estimated $38.4M and leaving 6,130,298 shares worth $440M. The position accounts for 0.07% of the portfolio, ranked #298.

UBS Group first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $942M in Q3 2017. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • UBS Group held 6,130,298 shares of CVS Health worth $440M as of Q1 2026.
  • UBS Group sold 498,915 CVS Health shares in Q1 2026, an estimated $38.4M.
  • CVS Health made up 0.07% of UBS Group's portfolio in Q1 2026, its #298 holding.
  • UBS Group first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's CVS Health position peaked at $942M in Q3 2017.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.